Doctor profile · Federal record
Dr. MELINA MARMARELIS, M.D.
Internal Medicine Physician (CMS: HEMATOLOGY/ONCOLOGY) · Internal Medicine Physician · PHILADELPHIA, PA
- NPI 1346688793
- Accepts Medicare
- MIPS 85.5 / 100 · 2023
- 13 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3400 CIVIC CENTER BLVD, 2 WEST
PHILADELPHIA, PA 191045127
(215) 615-0063
fax (215) 349-8144
Credentials & registration
- NPI registered
- June 2013 — 13 yrs on file
- Profile last updated
- September 10, 2019
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State licenses (2)
- Pennsylvania #MD464989 · Massachusetts #255530
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1346688793. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
400
Distinct HCPCS
6
Medicare allowed
$41,390
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 199 | 82 | $101 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 76 | 42 | $69 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 49 | 16 | $82 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 41 | 26 | $149 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 21 | 21 | $188 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 14 | 14 | $139 |
In context: peer comparison
Among 390 peers in this city , average services per provider: 132. This provider delivers 3.0× the peer median.Open Payments
Industry payments received
All-time total
$14,664
Transactions
14
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 3 | $6,435.00 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $2,450.00 | |
| Janssen Scientific Affairs, LLC | 1 | $2,025.00 | |
| AstraZeneca UK Limited | 1 | $1,665.00 | |
| AstraZeneca Pharmaceuticals LP | 2 | $882.50 | |
| Daiichi Sankyo Inc. | 2 | $589.76 | |
| Janssen Research & Development, LLC | 1 | $390.00 | |
| Janssen Biotech, Inc. | 2 | $226.59 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
115
Patients
16
Total drug cost
$599,928
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 28 | 16 | $256 |
| Tagrisso (Osimertinib Mesylate) | Brand | 19 | 0 | $351,906 |
| Folic Acid | Generic | 17 | 0 | $26 |
| Nifedipine Er (Nifedipine) | Brand | 16 | 0 | $490 |
| Oxycodone Hcl | Generic | 13 | 0 | $136 |
| Ondansetron Hcl | Generic | 11 | 0 | $96 |
| Tabrecta (Capmatinib Hydrochloride) | Brand | 11 | 0 | $247,019 |